Arbutus Biopharma Corp (ABUS)
3.955
+0.10
(+2.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.955
0.00 (0.00%)
After-Hours: 18:51
Arbutus Biopharma Total Assets (Quarterly): 160.04M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 160.04M |
| March 31, 2024 | 150.29M |
| December 31, 2023 | 144.40M |
| September 30, 2023 | 158.64M |
| June 30, 2023 | 176.82M |
| March 31, 2023 | 191.22M |
| December 31, 2022 | 195.42M |
| September 30, 2022 | 203.80M |
| June 30, 2022 | 215.84M |
| March 31, 2022 | 236.88M |
| December 31, 2021 | 204.48M |
| September 30, 2021 | 165.60M |
| June 30, 2021 | 135.38M |
| March 31, 2021 | 146.24M |
| December 31, 2020 | 137.08M |
| September 30, 2020 | 131.10M |
| June 30, 2020 | 97.62M |
| March 31, 2020 | 102.61M |
| December 31, 2019 | 105.54M |
| September 30, 2019 | 117.28M |
| June 30, 2019 | 192.57M |
| March 31, 2019 | 209.22M |
| December 31, 2018 | 227.90M |
| September 30, 2018 | 245.42M |
| June 30, 2018 | 277.01M |
| Date | Value |
|---|---|
| March 31, 2018 | 270.03M |
| December 31, 2017 | 237.16M |
| September 30, 2017 | 239.84M |
| June 30, 2017 | 255.08M |
| March 31, 2017 | 268.14M |
| December 31, 2016 | 275.92M |
| September 30, 2016 | 514.73M |
| June 30, 2016 | 530.86M |
| March 31, 2016 | 703.25M |
| December 31, 2015 | 712.29M |
| September 30, 2015 | 722.63M |
| June 30, 2015 | 773.82M |
| March 31, 2015 | 787.06M |
| December 31, 2014 | 118.18M |
| September 30, 2014 | 125.06M |
| June 30, 2014 | 132.07M |
| March 31, 2014 | 138.52M |
| December 31, 2013 | 71.72M |
| September 30, 2013 | 43.38M |
| June 30, 2013 | 45.91M |
| March 31, 2013 | 50.50M |
| December 31, 2012 | 52.60M |
| September 30, 2012 | 10.29M |
| June 30, 2012 | 11.63M |
| March 31, 2012 | 14.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
97.62M
Minimum
Jun 2020
236.88M
Maximum
Mar 2022
161.00M
Average
158.64M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| GlycoMimetics Inc | 24.42M |
| FibroGen Inc | 293.20M |
| Cidara Therapeutics Inc | 173.36M |
| Cue Biopharma Inc | 42.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.59M |
| Shareholders Equity (Quarterly) | 122.45M |
| Current Ratio | 6.560 |